News & Events

Vaccine Success!

Amazing news for everyone with the confirmation that AstraZeneca’s COVID-19 vaccine has been approved for emergency supply in the UK by the MHRA, the UK medicines regulator, with the first doses being released today (Dec. 30th 2020) so that vaccinations may begin early in the New Year.

As a key supplier of the AZD1222 vaccine to AstraZeneca for clinical trials, everyone at Symbiosis is tremendously proud to support  #Oxford #AstraZeneca #COVID19 #vaccine and be part of a world-class team at the forefront of the global fight against COVID-19.

Read the full story here: https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2020/astrazenecas-covid-19-vaccine-authorised-in-uk.html

Get In Touch.


By ticking the box and clicking “Submit” below, you consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Symbiosis Pharmaceutical Services believes may be of value to you, relevant to your work and tailored to your professional profile and interests. This may include promotional information on products, services and events provided or organised by Symbiosis Pharmaceutical Services. By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Symbiosis' processing of your personal data, including its transfer internationally and to third parties, in accordance with it's privacy policy.